Journal
BIOINFORMATICS
Volume 23, Issue 13, Pages I508-I518Publisher
OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btm207
Keywords
-
Categories
Funding
- NIAID NIH HHS [1U01AI061363-01, U01AI056464] Funding Source: Medline
- NLM NIH HHS [5T15LM007743] Funding Source: Medline
Ask authors/readers for more resources
Motivation: An important application of protein microarray data analysis is identifying a serodiagnostic antigen set that can reliably detect patterns and classify antigen expression profiles. This work addresses this problem using antibody responses to protein markers measured by a novel high-throughput microarray technology. The findings from this study have direct relevance to rapid, broad-based diagnostic and vaccine development. Results: Protein microarray chips are probed with sera from individuals infected with the bacteria Francisella tularensis, a category A biodefense pathogen. A two-step approach to the diagnostic process is presented ( 1) feature ( antigen) selection and ( 2) classification using antigen response measurements obtained from F. tularensis microarrays ( 244 antigens, 46 infected and 54 healthy human sera measurements). To select antigens, a ranking scheme based on the identification of significant immune responses and differential expression analysis is described. Classification methods including k-nearest neighbors, support vector machines (SVM) and k-Means clustering are applied to training data using selected antigen sets of various sizes. SVM based models yield prediction accuracy rates in the range of similar to 90% on validation data, when antigen set sizes are between 25 and 50. These results strongly indicate that the top-ranked antigens can be considered high-priority candidates for diagnostic development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available